CV Sciences (CVSI) Asset Writedowns and Impairment (2013 - 2020)
CV Sciences (CVSI) posted Asset Writedowns and Impairment of $6.2 million for Q4 2020, up 3031.31% sequentially from $198000.0 in Q4 2019, and up 3031.31% YoY from $198000.0 in Q1 2020.
CV Sciences (CVSI) Asset Writedowns and Impairment (2013 - 2020) Analysis & Trends
CV Sciences has reported Asset Writedowns and Impairment for 7 years, with the latest figure at $6.2 million in Q4 2020.
- Quarterly Asset Writedowns and Impairment rose 3031.31% year-over-year to $6.2 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $6.4 million (up 2613.56% YoY) and the FY2023 annual result came in at $251000.0, down 79.66% from the prior year.
- Asset Writedowns and Impairment grew to $6.2 million in Q4 2020 per CVSI's latest filing, from $198000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $6.2 million in Q4 2020 and troughed at -$47000.0 in Q4 2018.
- A 5-year average of $631384.2 and a median of $32000.0 in 2019 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2018 and 2019: Asset Writedowns and Impairment tumbled 156.92% in 2018, then surged 3300.0% in 2019.
- Over 5 years, Asset Writedowns and Impairment stood at $31003.0 in 2016, then jumped by 166.31% to $82565.0 in 2017, then sank by 156.92% to -$47000.0 in 2018, then soared by 521.28% to $198000.0 in 2019, then soared by 3031.31% to $6.2 million in 2020.
- According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $6.2 million, $198000.0, and $6000.0 for Q4 2020, Q4 2019, and Q3 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | CV Sciences | 3.90 Mn | 3.63 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 6.20 Mn |
| Dec 31, 2020 | 6.20 Mn |
| Dec 31, 2019 | 198,000.00 |
| Dec 31, 2019 | 198,000.00 |
| Sep 30, 2019 | 6,000.00 |
| Sep 30, 2019 | 6,000.00 |
| Jun 30, 2019 | 32,000.00 |
| Jun 30, 2019 | 32,000.00 |
| Dec 31, 2018 | -47,000.00 |
| Dec 31, 2018 | -47,000.00 |
| Sep 30, 2018 | 40,223.00 |
| Sep 30, 2018 | 40,223.00 |
| Jun 30, 2018 | -1,000.00 |
| Jun 30, 2018 | -1,000.00 |
| Mar 31, 2018 | 3,000.00 |
| Mar 31, 2018 | 3,000.00 |
| Dec 31, 2017 | 82,565.00 |
| Dec 31, 2017 | 82,565.00 |
| Jun 30, 2017 | 400,435.00 |
| Jun 30, 2017 | 400,435.00 |